FENGYUAN PHARMACEUTICAL (000153.SZ) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct23

FENGYUAN PHARMACEUTICAL released FY2025 9 Months Earnings on October 23 (BJT), actual revenue CNY 3.125 B, actual EPS CNY 0.2157

15:00

Fengyuan Pharmaceutical released FY2025 Q3 earnings on October 23 (BJT), actual revenue CNY 1.098 B, actual EPS CNY 0.0516

15:00

Aug21

Fengyuan Pharmaceutical released FY2025 Q2 earnings on August 21 After-Market (BJT), actual revenue CNY 1.086 B, actual EPS CNY 0.0822

01:00

Fengyuan Pharmaceutical released FY2025 Semi-Annual Earnings on August 21 After-Market BJT, actual revenue CNY 2.027 B, actual EPS CNY 0.1641

01:00

Aug14

Fengyuan Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

00:31

Jul9

Fengyuan Pharmaceutical Maintains CCC ESG Rating, Ranking Improves

01:15

Schedules & Filings

Schedules

Filings

Oct23

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.098 B, Net Income 24.01 M, EPS 0.0516

Aug22

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.086 B, Net Income 38.26 M, EPS 0.0822

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More